Advertisement
Advertisement
PTN
Palatin Technologies, Inc. Common Stock
7.36
USDSponsored
-0.41
-5.28%
Aug 10, 15:59 UTC -4
Closed
After-Market
7.54
+0.18
+2.45%
PTN Earnings Reports
Positive Surprise Ratio
PTN beat 19 of 38 last estimates.
50%
Next Report
Date of Next Report
Sep 21, 2026
Estimate for Q4 26 (Revenue/ EPS)
$1.26M
/-$1.21
Implied change from Q3 26 (Revenue/ EPS)
-67.80%
/+227.03%
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Palatin Technologies, Inc. Common Stock earnings per share and revenue
On May 13, 2026, PTN reported earnings of -0.37 USD per share (EPS) for Q3 26, beating the estimate of -1.25 USD, resulting in a 70.54% surprise. Revenue reached 3.92 million, compared to an expected 1.30 million, with a 202.51% difference. The market reacted with a -16.01% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -1.21 USD, with revenue projected to reach 1.26 million USD, implying an increase of 227.03% EPS, and decrease of -67.80% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Passage Bio, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.69
Actual
-$2.44
Surprise
+9.62%
Axsome Therapeutics, Inc
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.86
Actual
-$0.99
Surprise
-14.90%
Apogee Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$1.09
Actual
-$1.13
Surprise
-4.39%
Biohaven Ltd.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.91
Surprise
-21.67%
Septerna, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.43
Actual
-$0.28
Surprise
+33.26%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.55
Actual
-$0.61
Surprise
-9.83%
Sana Biotechnology, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.13
Surprise
+12.58%
Enanta Pharmaceuticals, Inc
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.67
Surprise
-28.80%
Orchestra BioMed Holdings, Inc. Ordinary Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.39
Actual
-Surprise
-
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
FAQ
What were Palatin Technologies, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Palatin Technologies, Inc. Common Stock reported EPS of -$0.37, beating estimates by 70.54%, and revenue of $3.92M, 202.51% above expectations.
How did the market react to Palatin Technologies, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -16.01%, changed from $19.70 before the earnings release to $16.55 the day after.
When is Palatin Technologies, Inc. Common Stock expected to report next?
The next earning report is scheduled for Sep 21, 2026.
What are the forecasts for Palatin Technologies, Inc. Common Stock's next earnings report?
Based on --
analysts, Palatin Technologies, Inc. Common Stock is expected to report EPS of -$1.21 and revenue of $1.26M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement